Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-28T02:45:32.478Z Has data issue: false hasContentIssue false
  • English
  • Français

Chlorpromazine Metabolism in Chronic Schizophrenics

Published online by Cambridge University Press:  29 January 2018

Gerald Samuel  and
Graham Mould
Gerald Samuel
Affiliation:
Newby Cottage, Crouch House Road, Edenbridge, Kent
Graham Mould
Affiliation:
Newby Cottage, Crouch House Road, Edenbridge, Kent
Get access Rights & Permissions [Opens in a new window]

Extract

The paper by Sved et al. (1) serves as a further reminder of the need for the monitoring of drugs used in psychiatry. We would however urge great caution in accepting the conclusions which the authors draw regarding resistance to chlorpromazine therapy. We fear a turn sequitur.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 120 , Issue 556 , March 1972 , pp. 356
Copyright
Copyright © Royal College of Psychiatrists, 1972 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sved, S., Perales, A., and Palaic, D. (Dec. 1971). Brit. J. Psychiat., 119, 589–96.Google Scholar
Curry, S. H., Lewis, D. M., and Samuel, G. (1971). Brit. med. J., i, 671–2.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.